Examine how Chorus, an autonomous R&D unit within Eli Lilly, functions as a lean approach to develop, de-risk and increase the value of early phase assets
Explore how this model aligns with Lilly’s capital fund strategy and works with outside venture capital to continue programs outside of Lilly’s core focus areas
Hear case examples and success stories since Chorus’ inception
